Anterix Inc. $ATEX Shares Acquired by Gamco Investors INC. ET AL

Gamco Investors INC. ET AL boosted its stake in shares of Anterix Inc. (NASDAQ:ATEXFree Report) by 32.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 422,470 shares of the company’s stock after purchasing an additional 102,400 shares during the quarter. Gamco Investors INC. ET AL’s holdings in Anterix were worth $9,223,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Gabelli Funds LLC boosted its position in Anterix by 6.5% during the 4th quarter. Gabelli Funds LLC now owns 304,907 shares of the company’s stock valued at $6,656,000 after purchasing an additional 18,625 shares during the period. Marshall Wace LLP boosted its position in Anterix by 51.6% during the 3rd quarter. Marshall Wace LLP now owns 286,581 shares of the company’s stock worth $6,153,000 after acquiring an additional 97,601 shares during the period. Bank of America Corp DE boosted its position in Anterix by 25.2% during the 2nd quarter. Bank of America Corp DE now owns 208,445 shares of the company’s stock worth $5,347,000 after acquiring an additional 42,018 shares during the period. Qube Research & Technologies Ltd boosted its position in Anterix by 33.1% during the 2nd quarter. Qube Research & Technologies Ltd now owns 203,144 shares of the company’s stock worth $5,211,000 after acquiring an additional 50,564 shares during the period. Finally, Tudor Investment Corp ET AL boosted its position in Anterix by 9.8% during the 3rd quarter. Tudor Investment Corp ET AL now owns 128,681 shares of the company’s stock worth $2,763,000 after acquiring an additional 11,514 shares during the period. Institutional investors and hedge funds own 87.67% of the company’s stock.

Anterix Stock Up 6.9%

Shares of ATEX stock opened at $58.78 on Wednesday. The stock has a 50-day simple moving average of $43.54 and a 200 day simple moving average of $31.45. Anterix Inc. has a fifty-two week low of $17.58 and a fifty-two week high of $59.80. The stock has a market capitalization of $1.10 billion, a P/E ratio of 13.51 and a beta of 0.86.

Analysts Set New Price Targets

A number of research analysts have issued reports on ATEX shares. Zacks Research lowered Anterix from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 5th. Weiss Ratings upgraded Anterix from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, April 21st. One equities research analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $50.00.

Get Our Latest Analysis on Anterix

Anterix Company Profile

(Free Report)

Anterix, Inc is a specialized telecommunications company focused on delivering private broadband networks for utilities and other critical infrastructure industries. The company owns and operates dedicated 900 MHz spectrum that enables reliable, secure and high-performance wireless communications to support grid modernization, smart metering, distribution automation and other mission-critical applications. By leveraging this spectrum, Anterix helps electric, water and gas utilities deploy advanced communications capabilities to enhance operational efficiency and resiliency.

At the core of Anterix’s offering is its licensed 900 MHz spectrum, which provides superior propagation characteristics compared with unlicensed options and allows for cost-effective coverage over expansive service territories.

Further Reading

Want to see what other hedge funds are holding ATEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anterix Inc. (NASDAQ:ATEXFree Report).

Institutional Ownership by Quarter for Anterix (NASDAQ:ATEX)

Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.